Home > Insider Trading > Filing (0001209191-14-038146)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1534986	Md Joao Siffert	20 Enterprise, Suite 200 Aliso Viejo CA 92656	Svp, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-05-28	13,547	$5.18	230,980	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-05-28	10,547	$0.00	10,547	$1.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,609		2021-12-15	No	4	M	Direct

Footnotes

Represents the weighted-average price at which shares were sold within a range between $5.15 and $5.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying Restricted Stock Grants granted to the Reporting Person, which are subject to certain vesting conditions. Following the sales reported on this Form 4, the Reporting Person has a total of 185,938 options to purchase shares of common stock that are vested and immediately exercisable and a total of 221,171 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 211,045 unvested Restricted Stock Units, of which 43,000 are performance-based Restricted Stock Units.
The option was granted on December 15, 2011 and vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
Includes previously reported options granted to the Reporting Person, which are subject to certain vesting conditions.